TherapeuticsMD Inc (TXMD)
1.92
+0.07
(+3.78%)
USD |
NASDAQ |
Jun 21, 16:00
1.89
-0.03
(-1.56%)
Pre-Market: 08:38
TherapeuticsMD Cash from Operations (Quarterly): -0.229M for March 31, 2024
Cash from Operations (Quarterly) Chart
Historical Cash from Operations (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | -0.229M |
| December 31, 2023 | -4.96M |
| September 30, 2023 | -6.028M |
| June 30, 2023 | -3.392M |
| March 31, 2023 | -8.701M |
| December 31, 2022 | 30.24M |
| September 30, 2022 | 17.72M |
| June 30, 2022 | -20.72M |
| March 31, 2022 | -17.87M |
| December 31, 2021 | -39.56M |
| September 30, 2021 | -38.22M |
| June 30, 2021 | -26.53M |
| March 31, 2021 | -38.38M |
| December 31, 2020 | -30.36M |
| September 30, 2020 | -34.05M |
| June 30, 2020 | -55.95M |
| March 31, 2020 | -39.11M |
| December 31, 2019 | -50.82M |
| September 30, 2019 | -26.22M |
| June 30, 2019 | -50.51M |
| March 31, 2019 | -38.16M |
| December 31, 2018 | -28.14M |
| September 30, 2018 | -34.07M |
| June 30, 2018 | -24.95M |
| March 31, 2018 | -19.65M |
| Date | Value |
|---|---|
| December 31, 2017 | -20.81M |
| September 30, 2017 | -16.68M |
| June 30, 2017 | -18.14M |
| March 31, 2017 | -20.53M |
| December 31, 2016 | -15.62M |
| September 30, 2016 | -18.80M |
| June 30, 2016 | -15.32M |
| March 31, 2016 | -19.40M |
| December 31, 2015 | -16.61M |
| September 30, 2015 | -18.44M |
| June 30, 2015 | -24.85M |
| March 31, 2015 | -19.15M |
| December 31, 2014 | -15.29M |
| September 30, 2014 | -11.46M |
| June 30, 2014 | -10.07M |
| March 31, 2014 | -8.706M |
| December 31, 2013 | -4.769M |
| September 30, 2013 | -5.314M |
| June 30, 2013 | -7.176M |
| March 31, 2013 | -3.509M |
| December 31, 2012 | -4.007M |
| September 30, 2012 | -3.081M |
| June 30, 2012 | -3.198M |
| March 31, 2012 | -2.452M |
| December 31, 2011 | -1.885M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (Quarterly) Range, Past 5 Years
-55.95M
Minimum
Jun 2020
30.24M
Maximum
Dec 2022
-22.18M
Average
-26.38M
Median
Cash from Operations (Quarterly) Benchmarks
| NovaBay Pharmaceuticals Inc | -1.572M |
| Palatin Technologies Inc | -8.607M |
| iBio Inc | -3.654M |
| Theriva Biologics Inc | -4.881M |
| Oragenics Inc | -3.064M |
Cash from Operations (Quarterly) Related Metrics
| Free Cash Flow | -14.61M |
| Free Cash Flow Per Share (Quarterly) | -0.0199 |
| Free Cash Flow to Equity (Quarterly) | -0.229M |
| Free Cash Flow to Firm (Quarterly) | -0.229M |
| Free Cash Flow Yield | -69.98% |